Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinson's disease and sleep.

P Clarenbach1

  • 1Dept. of Neurology, Ev. Johannes-Hospital. Bielefeld, Germany.

Journal of Neurology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Patients with idiopathic Parkinson's disease often experience sleep disorders and daytime sleepiness due to reduced sleep quality. Sudden sleep onset, similar to cataplexy, is also reported with certain dopamine agonists.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep.

European journal of neurology·2006
Same author

Sleep and stroke.

Revue neurologique·2002
Same author

[Restless legs syndrome and periodic limb movements in sleep].

Der Nervenarzt·2001
Same author

Workshop I: Parkinson's disease and sleep--results of the group discussion.

Journal of neurology·2001
Same author

[Isolated reversible unilateral paresis of hypoglossal nerve in tonsillitis--case report].

Der Nervenarzt·2000

Area of Science:

  • Neurology
  • Sleep Medicine
  • Pharmacology

Background:

  • Idiopathic Parkinson's disease frequently leads to sleep disturbances and daytime somnolence.
  • Key contributing factors include decreased total sleep time, reduced sleep efficiency, and increased respiratory and motor arousals.

Purpose of the Study:

  • To investigate the relationship between Parkinson's disease, sleep disorders, and daytime sleepiness.
  • To differentiate typical sleepiness in Parkinson's disease from potential "sleep attacks" associated with specific medications.

Main Methods:

  • Review of existing literature and clinical observations regarding sleep disorders in Parkinson's disease patients.
  • Analysis of reported cases of sudden sleep onset associated with dopamine agonist use.

Related Experiment Videos

Main Results:

  • Parkinson's disease patients exhibit reduced sleep duration and efficiency, alongside increased arousals, contributing to daytime sleepiness.
  • While distinct from cataplexy, sudden sleep onset has been reported with newer dopamine agonists (pramipexole, ropinirole) at high doses.
  • Evidence for a novel cataplexy-like phenomenon is limited; older dopamine agonists and Levodopa/Carbidopa also report sudden sleep onset.

Conclusions:

  • Daytime sleepiness in Parkinson's disease is multifactorial, linked to disease progression and sleep fragmentation.
  • Sudden sleep onset events, while concerning, may not represent a novel cataplexy-like syndrome and have precedents with other dopaminergic therapies.